Combination of the PAM4 and CA19-9 biomarkers to improve the detection of pancreatic adenocarcinoma.

被引：0
|
作者：
Gold, David V.
Gaedcke, Jochen
Ghadimi, B. Michael
Goggins, Michael
Hruban, Ralph H.
Liu, Mengling
Newsome, Guy
Goldenberg, David M.
机构：
[1] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA
[2] Univ Goettingen, Univ Med Ctr, Gottingen, Germany
[3] Johns Hopkins Med Inst, Baltimore, MD USA
[4] New York Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim, Young Choon
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Shin, Jun Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1869 - 1875
  • [22] PROGNOSTIC VALUE OF POST OPERATIVE CA19-9 IN PATIENTS UNDERGOING PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA
    Malde, D. J.
    Jeans, E.
    De Liguori, N.
    Deshpande, R.
    Ammori, B. J.
    Sherlock, D. J.
    O'Reilly, D.
    GUT, 2012, 61 : A114 - A115
  • [23] Ca19-9 and pancreatic cancer: Is it really that good?
    Morris-Stiff, Gareth
    Taylor, Mark A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (02) : 88 - 89
  • [24] CA19-9 for detecting recurrence of pancreatic cancer
    Azadeh Azizian
    Felix Rühlmann
    Tanja Krause
    Markus Bernhardt
    Peter Jo
    Alexander König
    Mathias Kleiß
    Andreas Leha
    Michael Ghadimi
    Jochen Gaedcke
    Scientific Reports, 10
  • [25] CA19-9 Kinetics Following Radiation Therapy Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma
    Shultz, D. B.
    Cato, C.
    Jenny, S. L.
    Koong, A. C.
    Daniel, C. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S314 - S315
  • [26] Clinical Utility of the Combined Use of CA19-9 and DUPAN-2 in Pancreatic Adenocarcinoma
    Sumiyoshi, Tatsuaki
    Uemura, Kenichiro
    Shintakuya, Ryuta
    Okada, Kenjiro
    Baba, Kenta
    Harada, Takumi
    Serikawa, Masahiro
    Ishii, Yasutaka
    Nakamura, Shinya
    Arihiro, Koji
    Murakami, Yoshiaki
    Takahashi, Shinya
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4665 - 4672
  • [27] Molecular analysis of CEA CA19-9 in pancreatic adenocarcinoma diagnosed by EUS guided FNA
    Wang, Dong
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (02) : S240 - S240
  • [28] CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?
    Gao, Xiang
    In, Haejin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4839 - 4840
  • [29] Prognostic value of post operative Ca19-9 in patients undergoing pancreaticoduodenectomy for Pancreatic Adenocarcinoma
    Jeans, E.
    Malde, D. J.
    O'Reilly, D.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 94 - 94
  • [30] Preoperative CA19-9 is a Predictive Value for Early Recurrence After Resection of Pancreatic Adenocarcinoma
    Suzumura, K.
    Asano, Y.
    Kosaka, H.
    Iimuro, Y.
    Hirano, T.
    Okada, T.
    Uyama, N.
    Nakamura, I.
    Kondo, Y.
    Hai, S.
    Sueoka, H.
    Yada, A.
    Ohashi, K.
    Okamoto, T.
    Kurimoto, A.
    Fujimoto, J.
    PANCREAS, 2014, 43 (08) : 1412 - 1412
12345